Search for: "Abbvie Inc"
Results 1 - 20
of 142
Sort by Relevance
|
Sort by Date
5 Mar 2024, 10:55 am
AbbVie, Inc., et al., Adventist Health System, a 340B covered entity, is suing pharmaceutical manufacturers AbbVie, AstraZeneca, Novartis, Sanofi, and Sandoz alleging that the manufacturers caused violations of the False Claims Act and various state anti-fraud laws when calculating the 340B price for drugs with price increases that outpaced inflation. [read post]
19 Jan 2024, 4:00 am
” In the recent decision, AbbVie Corporation v. [read post]
11 Jan 2024, 12:03 am
The FIE determination released in fall 2023 involves the Reference Product AbbVie’s Humira (adalimumab) and two interchangeable biosimilars—first approved is Cyltezo (adalimumab-adbm), filed by Boehringer Ingelheim Pharmaceuticals, Inc, which was followed by Abrilada (adalimumab-afzb), filed by Pfizer. [read post]
4 Jan 2024, 9:42 am
As in other Federal Circuit decisions like AbbVie Deutschland GmbH & Co., KG v. [read post]
20 Dec 2023, 5:00 am
Monoclonal Antibodies Inc., 1985) protected large genus claims. [read post]
1 Oct 2023, 12:30 pm
The Chamber was joined by a handful of affiliates -- along with AbbVie, Inc., manufacturer of the lucrative [read post]
11 Nov 2022, 9:40 am
Cir. 2021); Plexxikon Inc. v. [read post]
11 Oct 2022, 4:45 pm
In 2021 alone, Humira generated $20.7 billion in revenue for its manufacturer, AbbVie, Inc. [read post]
4 Oct 2022, 6:14 am
(Northfield) FCA US, LLC (Belvidere) AbbVie, Inc. [read post]
22 Sep 2022, 9:54 am
AbbVie Inc, 7th U.S. [read post]
8 Sep 2022, 12:35 pm
AbbVie Inc., et al., this recent decision of the U.S. [read post]
16 Aug 2022, 8:00 am
Abbott Laboratories, Inc. and AbbVie, Inc., 2022 IL App (1st) 210478 (June 23, 2022). [read post]
2 Aug 2022, 8:37 pm
AbbVie Inc., the Seventh Circuit Court of Appeals affirmed the District Court's decision to dismiss the complaint in a unanimous verdict that took the Court sixteen months... [read post]
6 Jul 2022, 7:55 pm
Abbvie Inc. v. [read post]
17 Mar 2022, 2:32 pm
See Abbvie Deutschland GmbH & Co. v. [read post]
9 Jan 2022, 1:45 am
In Abbvie v Janssen, for example, a claim directed to a functionally defined anti-Il-12 antibody was found invalid for lack of written description despite disclosure in the specification of 300 example antibodies. [read post]
16 Dec 2021, 12:15 pm
She recommended that Teva and its subsidiaries receive 50 percent of liability and Anda, Inc., the other 50 percent. [read post]
1 Dec 2021, 1:29 pm
Pfizer, Inc. [read post]
7 Nov 2021, 9:31 am
The defendants included Johnson & Johnson, Teva Pharmaceutical Industries, Endo International and AbbVie Inc. [read post]
1 Nov 2021, 8:09 am
AbbVie Inc., et al., No. 14-5151 (E.D. [read post]
